Is CHMX Stock Undervalued?

A comprehensive valuation analysis of Next-Chemx Corporation. (CHMX) examining current multiples, intrinsic value, and comparing to analyst expectations.

8 min readView Full Analysis

Valuation Verdict

Fairly Valued

0.0% downside risk

Based on our analysis, Next-Chemx Corporation. appears to be fairly valued at the current price of $0.01.

Current Valuation Metrics

Valuation ratios help us understand how the market is pricing CHMX relative to its fundamentals. Let's examine the key multiples investors are paying today.

P/E Ratio
N/A
P/B Ratio
283.83
High
P/S Ratio
127.75
High
EV/EBITDA
N/A

Understanding the Metrics

  • P/E Ratio: Not currently profitable or data unavailable.
  • P/B Ratio: A P/B of 283.83 means investors pay $283.83 for every $1 of book value.
  • P/S Ratio: The price-to-sales ratio of 127.75 indicates how much investors value each dollar of revenue.
  • EV/EBITDA: EBITDA data not available.

Fair Value Estimate

Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Next-Chemx Corporation. stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.

Current Price
$0.01
vs
Fair Value Estimate
N/A

Unable to calculate a reliable fair value estimate due to insufficient financial data or negative cash flows. This is common for early-stage growth companies or those undergoing restructuring.

Investment Conclusion

Bottom Line

Next-Chemx Corporation. (CHMX) appears fairly valued at $0.01, trading in line with our fundamental analysis. The stock may be appropriate for investors seeking exposure to Industrials without significant valuation risk.

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.

Compare with Peers

See how Next-Chemx Corporation. stacks up against similar companies

Popular Valuation Analysis

Explore valuation analysis for top stocks